FOXP1 and ovarian carcinoma: In addition, a recent study has shown that miR-29c-3p downregulates ATG14 by inducing the expression of FOXP1 to inhibit autophagy and promote cisplatin resistance in ovarian cancer cells (Hu et al., 2020).